Evidence map›Paper›PMID 32597011›Full record

ArticleCancer medicine2020

Clinical and cytopathological characteristics of HTLV-1

Katsumi Kobata, Shoichi Kimura, Yasuhito Mihashi, Hiromi Iwasaki, Shuichi Nonaka, Shinji Matsumoto, Yasushi Takamatsu, Ilseung Choi, Shigeto Kawauchi, Kenji Ishitsuka and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Diagnostic Tools and Biomarkers for Severe Drug Eruptions.International journal of molecular sciences · 2021
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Katsumi KobataDivision of Diagnostic Pathology, Faculty of Medicine, Fukuoka University Hospital, Fukuoka, Japan.
Shoichi KimuraDepartments of Pathology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
Yasuhito MihashiDepartments of Pathology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
Hiromi IwasakiDepartments of Hematology, National Hospital Organization, Kyushu Medical Center, Fukuoka, Japan.ORCID 0000-0003-3711-272X
Shuichi NonakaDepartments of Pathology, National Hospital Organization, Kyushu Medical Center, Fukuoka, Japan.
Shinji MatsumotoDivision of Diagnostic Pathology, Faculty of Medicine, Fukuoka University Hospital, Fukuoka, Japan.ORCID 0000-0002-1566-4681
Yasushi TakamatsuDivision of Medical Oncology, Hematology and Infectious Diseases, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
Ilseung ChoiDepartment of Hematology, National Hospital Organization, Kyushu Cancer Center, Fukuoka, Japan.
Shigeto KawauchiDepartments of Pathology, National Hospital Organization, Kyushu Medical Center, Fukuoka, Japan.
Kenji IshitsukaDepartment of Internal Medicine, Faculty of Medicine, Kagoshima University, Kagoshima, Japan.ORCID 0000-0002-7030-497X
Morishige TakeshitaDivision of Diagnostic Pathology, Faculty of Medicine, Fukuoka University Hospital, Fukuoka, Japan.ORCID 0000-0003-0267-2081
Fukuoka University · JPNational Kyushu Medical Center · JPFukuoka University Hospital · JPKagoshima University · JPNational Hospital Organization Kyushu Cancer Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHuman T-lymphotropic virus-1 (HTLV-1)

methodsCytological and immunohistological features, HTLV-1 proviral DNA integration, and rearrangements of the T-cell receptor (TCR) Cβ1 gene were examined in 11 HTLV-1

resultsSix patients were classified as HTLV-1

conclusionsHTLV-1

Indexed as

Gene Rearrangement, beta-Chain T-Cell Antigen ReceptorGenes, T-Cell Receptor betaHodgkin DiseaseHuman T-lymphotropic virus 1Leukemia-Lymphoma, Adult T-CellAdultAgedAntigens, CD20Cell SizeDNA, ViralEpstein-Barr Virus InfectionsFemaleHumansLymphocytes, Tumor-InfiltratingMaleMiddle AgedAntigens, CD20DNA, Viral

Identifiers

PMID32597011
PMCPMC7433818
OpenAlexW3037328488

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.